Journals / Güncel Pediatri / 2011 / Cilt: 9 - Sayı: 2

Neonatal Alloimmune Thrombocytopenia

Neonatal Alloimmün Trombositopeni

Pages
93–96
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis, treatment and giving information to the parents about the risks of the subsuquent pregnancies are important issues due to increased morbidity and mortality of the disease. (Journal of Current Pediatrics 2011; 9: 93-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neonatal alloimmune thrombocytopenia is a rare disease causing serious thrombocytopenia during neotatal period.
📊
Key Findings & Data:The recurrence risk increases in the subsequent pregnancies.
💡
Conclusion & Impact:Early diagnosis, treatment and giving information to the parents about the risks of the subsuquent pregnancies are important issues due to increased morbidity and mortality of the disease. (Journal of Current Pediatrics 2011; 9: 93-6)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Neonatal alloimmune thrombocytopenia is a rare disease causing serious thrombocytopenia during neotatal period. Antibodies developed against fetal thrombocytes due to fetal-maternal platelet antigen incompatibility cause thrombocytopenia both in intrauterine period and afterwards. The clinical symptoms vary from mild to severe. Half of the cases occurs during first pregnancy. The recurrence risk increases in the subsequent pregnancies. The event is limited when the antibodies are cleared away. However, a careful close follow-up is needed both for the mothers and fetus/babies and the treatment should be immediately started when it is indicated. Early diagnosis, treatment and giving information to the parents about the risks of the subsuquent pregnancies are important issues due to increased morbidity and mortality of the disease. (Journal of Current Pediatrics 2011; 9: 93-6)

Özet

ÖZET Neonatal Alloimmün Trombositopeni (NAT) yenidoğan döneminde ağır trombositopeniye neden olan nadir bir hastalıktır. Anne ve bebek arasındaki trombosit antijen uyumsuzluğu sonucunda annede fetal trombositlere karşı gelişen antikorlar, fetusa geçerek intrauterin dönemden itibaren trombositopeniye yol açabilir. Klinik bulgular hafif ya da ağır olabilir. Olguların yaklaşık yarısı ilk gebelikte görülür. İzleyen gebeliklerde görülme sıklığı artar. Olay antikorların uzaklaşması ile kendini sınırlar. Ancak, gebelik süresince anne ve fetusun dikkatli ve yakından izlenmesi ve endikasyonu olduğu takdirde tedavinin hemen düzenlenmesi gerekir. Artmış mortalite ve morbiditesi nedeniyle erken tanınması, tedavi edilmesi ve ailenin sonraki gebeliklerdeki riskler hakkında bilgilendirilmesi önemlidir. (Güncel Pedi atri 2011; 9: 93-6)

🔖

Cite This Article

GÜNEŞ, A. M., EVİM, M. S. (2022). Neonatal Alloimmune Thrombocytopenia. Güncel Pediatri, Cilt: 9 - Sayı: 2, 93–96. https://ajindex.com/articles/528057

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997;89:4402-6
  2. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6
  3. Ward MJ, Pauliny J, Lipper EG, Bussel JB. Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children. Am J Perinatol 2006;23: 487-92
  4. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6
  5. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7
  6. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6
  7. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986;68:488-92
  8. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55
  9. Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004;44:1220-5
  10. Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl Immunol 2002;10:165-81
  11. Castro V, Kroll H, Origa AF, Falconi MA, Marques SB, Marba ST et al. A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Transfusion 2007;47:59-66
  12. Bussel JB, Sola-Visner M. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009;33:35-42
  13. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008;93:870-7
  14. Kaplan C. Neonatal alloimmune thrombocytopenia. Haematologica 2008;93:805-7
  15. Sharif U, Kuban K.